L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lytix Biopharma AS
Total Current Liabilities Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Total Current Liabilities
kr12.5m
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Current Liabilities
kr155.5m
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
9%
B
Bergenbio ASA
OSE:BGBIO
Total Current Liabilities
kr43.2m
CAGR 3-Years
-14%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Current Liabilities
kr15.5m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
7%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Current Liabilities
$15.1m
CAGR 3-Years
16%
CAGR 5-Years
60%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Current Liabilities
kr5.2m
CAGR 3-Years
-64%
CAGR 5-Years
-45%
CAGR 10-Years
-3%

See Also

What is Lytix Biopharma AS's Total Current Liabilities?
Total Current Liabilities
12.5m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Total Current Liabilities amounts to 12.5m NOK.

What is Lytix Biopharma AS's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-7%

Over the last year, the Total Current Liabilities growth was -30%.

Back to Top